BIIB vs INSP · P/E 21, rev $9.89B vs P/E 9.4, rev $405.2M
Biogen Inc (BIIB) versus Inspire Medical Systems Inc (INSP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Inspire Medical Systems Inc (INSP) is a medical devices company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported INSP revenue for 2026-06-30 was $405.2M. Net income was -$11.0M. Revenue was up 98.0% from 2026-03-31 to 2026-06-30. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
Not investment advice. Open the BIIB and INSP stock pages for the full models.
Not investment advice.